Kaiser Elisabeth

Dr. Kaiser Elisabeth

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Lars KaestnerLars Kaestner
Lars Kaestner
QTQinghai Tian
Qinghai Tian
KEKaiser Elisabeth
Kaiser Elisabeth
WXWenying Xian
Wenying Xian
AMAndreas Müller
Andreas Müller
PLPeter Lipp
Peter Lipp
Membrane potentials display the cellular status of non-excitable cells and mediate communication between excitable cells via action potentials. The use of genetically encoded biosensors employing fluorescent proteins allows a non-invasive biocompatible way to read out the membrane potential in cardiac myocytes and other cells of the circulation system. Although the approaches to design such biosensors date back to the time when the first fluorescent-protein based Förster Resonance Energy Transfer (FRET) sensors were constructed, it took 15 years before reliable sensors became readily available. Here, we review different developments of genetically encoded membrane potential sensors. Furthermore, it is shown how such sensors can be used in pharmacological screening applications as well as in circulation related basic biomedical research. Potentials and limitations will be discussed and perspectives of possible future developments will be provided.

17 March 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
CZCosima Maria Felicitas Zemlin
Cosima Maria Felicitas Zemlin
LALaura Alicia Altmayer
Laura Alicia Altmayer
CSCaroline Stuhlert
Caroline Stuhlert
JSJulia Theresa Schleicher
Julia Theresa Schleicher
CWCarolin Wörmann
Carolin Wörmann
CMCarolin Müller
Carolin Müller
(1) Background: Vitamin D plays an important role in many types of cancer. It was the aim of this study to analyze serum 25-hydroxyvitamin D (25(OH)D) levels in newly diagnosed breast cancer patients, and the association with prognostic and lifestyle factors. (2) Methods: 110 non-metastatic breast cancer patients were included in the prospective observational “BEGYN” study at Saarland University Medical Center between September 2019 and January 2021. At the initiation visit, serum 25(OH)D levels were measured. Clinicopathological data on prognosis, nutrition, and lifestyle were extracted from data files and obtained using a questionnaire. (3) Results: Median serum 25(OH)D in breast cancer patients was 24 ng/mL (range 5–65 ng/mL), with 64.8% of patients being vitamin D deficient. 25(OH)D was higher among patients that reported the use of vitamin D supplements (43 ng/mL versus 22 ng/mL; p < 0.001), and in summer compared to other seasons (p = 0.03). Patients with moderate vitamin D deficiency were less likely to have triple negative breast cancer (p = 0.047). (4) Conclusions: Routinely measured vitamin D deficiency is common in breast cancer patients and needs to be detected and treated. However, our results do not support the hypothesis that vitamin D deficiency may be a main prognostic factor for breast cancer.

12 May 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
MFMats Ingmar Fortmann
Mats Ingmar Fortmann
MDMarie-Theres Dammann
Marie-Theres Dammann
AHAlexander Humberg
Alexander Humberg
BSBastian Siller
Bastian Siller
GSGuido Stichtenoth
Guido Stichtenoth
OCon behalf of the German Neonatal Network (GNN) and the PRIMAL Consortium
on behalf of the German Neonatal Network (GNN) and the PRIMAL Consortium
This study is aimed at detecting the rate of untimely immunization in a large cohort of extremely low gestational age neonates (ELGANs) of the German Neonatal Network (GNN) and at addressing risk factors for delayed vaccination and associated long-term consequences. We performed an observational study of the GNN between 1st January 2010 and 31st December 2019. The immunization status for the hexavalent and pneumococcal immunization was evaluated in n = 8401 preterm infants <29 weeks of gestation. Univariate analysis and logistic/linear regression models were used to identify risk factors for vaccination delay and outcomes at a 5-year follow-up. In our cohort n = 824 (9.8%) ELGANs did not receive a timely first immunization with the hexavalent and pneumococcal vaccine. Risk factors for delayed vaccination were SGA status (18.1% vs. 13.5%; OR 1.3; 95% CI: 1.1–1.7), impaired growth and surrogates for complicated clinical courses (i.e., need for inotropes, necrotizing enterocolitis). At 5 years of age, timely immunized children had a lower risk of bronchitis (episodes within last year: 27.3% vs. 37.7%; OR 0.60, 95% CI: 0.42–0.86) but spirometry measures were unaffected. In conclusion, a significant proportion of ELGANs are untimely immunized, specifically those with increased vulnerability, even though they might particularly benefit from the immune-promoting effects of a timely vaccination.

2 April 2024 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Open access
DSDirk Schneider
Dirk Schneider
RWRegine Weber
Regine Weber
NNNasenien Nourkami-Tutdibi
Nasenien Nourkami-Tutdibi
MBMichelle Bous
Michelle Bous
SGSybelle Goedicke-Fritz
Sybelle Goedicke-Fritz
KEKaiser Elisabeth
Kaiser Elisabeth
Purpose: To analyse the reliability of ultrasound‐guided measurement of the cartilage thickness at the medial femoral condyle in athletically active children and adolescents before and after mechanical load in relation to age, sex and type of sport.Methods: Three successive measurements were performed in 157 participants (median/min–max age: 13.1/6.0–18.0 years, 106 males) before and after mechanical load by squats at the same site of the medial femoral condyle by defined transducer positioning. Test–retest reliability was examined using Cronbach's calculation. Differences in cartilage thickness were analysed with respect to age, sex and type of practiced sports, respectively.Results: Excellent reliability was achieved both before and after mechanical load by 30 squats with a median cartilage thickness of 1.9 mm (range: 0.5–4.8 mm) before and 1.9 mm (0.4–4.6 mm) after mechanical load. Male cartilages were thicker (p < 0.01) before (median: 2.0 mm) and after (2.0 mm) load when compared to female cartilage (before: 1.6 mm; after: 1.7 mm). Median cartilage thickness was about three times higher in karate athletes (before: 2.3 mm; after: 2.4 mm) than in sports shooters (0.7; 0.7 mm). Cartilage thickness in track and field athletes, handball players and soccer players were found to lay in‐between. Sport type related thickness changes after mechanical load were not significant.Conclusion: Medial femoral condyle cartilage thickness in childhood correlates with age, sex and practiced type of sports. Ultrasound is a reliable and simple, pain‐free approach to evaluate the cartilage thickness in children and adolescents.Level of Evidence: Level III.

Verified
Journal Article
Open access
PDF file
MBMichelle Bous
Michelle Bous
CSCharline Schmitt
Charline Schmitt
MHMuriel Charlotte Hans
Muriel Charlotte Hans
RWRegine Weber
Regine Weber
NNNasenien Nourkami-Tutdibi
Nasenien Nourkami-Tutdibi
SGSybelle Goedicke-Fritz
Sybelle Goedicke-Fritz
Cord blood represents a link between intrauterine and early extrauterine development. Cord blood cells map an important time frame in human immune imprinting processes. It is unknown whether the sex of the newborn affects the lymphocyte subpopulations in the cord blood. Nine B and twenty-one T cell subpopulations were characterized using flow cytometry in human cord blood from sixteen male and twenty-one female newborns, respectively. Except for transitional B cells and naïve B cells, frequencies of B cell counts across all subsets was higher in the cord blood of male newborns than in female newborns. The frequency of naïve thymus-negative Th cells was significantly higher in male cord blood, whereas the remaining T cell subpopulations showed a higher count in the cord blood of female newborns. Our study is the first revealing sex differences in the B and T cell subpopulations of human cord blood. These results indicate that sex might have a higher impact for the developing immune system, urging the need to expand research in this area.

4 July 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
LALaura Alicia Altmayer
Laura Alicia Altmayer
MLMarina Lang
Marina Lang
JSJulia Theresa Schleicher
Julia Theresa Schleicher
CSCaroline Stuhlert
Caroline Stuhlert
CWCarolin Wörmann
Carolin Wörmann
CZCosima Maria Felicitas Zemlin
Cosima Maria Felicitas Zemlin
(1) Background: The role of selenium in cancer biology remains poorly understood. Our aim was to study the course of selenium serum levels and the use of selenium supplements during breast cancer therapy. (2) Methods: Serum selenium levels, clinical–pathological data, selenium supplementation, and lifestyle factors were monitored quarterly over one year. (3) Results: A total of 110 non-metastatic breast cancer patients were enrolled in the prospective observational “BEGYN-1” study. At baseline, 2.9% of patients were selenium-deficient (120 ng/mL), and 6.4% received substitution. The median selenium level was 81.5 ng/mL and ranged between 78.7 and 84.5 ng/mL within the year. A total of 25.3% of the patients received supplementation, resulting in significantly higher selenium levels (p < 0.05). A total of 8.7–28.6% of the patients using supplements were overdosed. Selenium levels strongly correlated with mushroom consumption (p = 0.003), but no association was found with therapy or clinical characteristics. (4) Conclusions: Although selenium deficiency is rare, serum selenium levels should be assessed in breast cancer patients. Mushrooms and nuts should be preferred over supplements to correct selenium deficiency. Ruling out selenium deficiency helps prevent the risk of selenosis and avoid unnecessary, costly supplementation in patients who are often financially burdened due to their disease.